Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Dec 15;102(12):2136–2145. doi: 10.1172/JCI4188

Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor.

L Criscione 1, P Rigollier 1, C Batzl-Hartmann 1, H Rüeger 1, A Stricker-Krongrad 1, P Wyss 1, L Brunner 1, S Whitebread 1, Y Yamaguchi 1, C Gerald 1, R O Heurich 1, M W Walker 1, M Chiesi 1, W Schilling 1, K G Hofbauer 1, N Levens 1
PMCID: PMC509168  PMID: 9854049

Abstract

The new neuropeptide Y (NPY) Y5 receptor antagonist CGP 71683A displayed high affinity for the cloned rat NPY Y5 subtype, but > 1, 000-fold lower affinity for the cloned rat NPY Y1, Y2, and Y4 subtypes. In LMTK cells transfected with the human NPY Y5 receptor, CGP 71683A was without intrinsic activity and antagonized NPY-induced Ca2+ transients. CGP 71683A was given intraperitoneally (dose range 1-100 mg/kg) to a series of animal models of high hypothalamic NPY levels. In lean satiated rats CGP 71683A significantly antagonized the increase in food intake induced by intracerebroventricular injection of NPY. In 24-h fasted and streptozotocin diabetic rats CGP 71683A dose-dependently inhibited food intake. During the dark phase, CGP 71683A dose-dependently inhibited food intake in free-feeding lean rats without affecting the normal pattern of food intake or inducing taste aversion. In free-feeding lean rats, intraperitoneal administration of CGP 71683A for 28 d inhibited food intake dose-dependently with a maximum reduction observed on days 3 and 4. Despite the return of food intake to control levels, body weight and the peripheral fat mass remained significantly reduced. The data demonstrate that the NPY Y5 receptor subtype plays a role in NPY-induced food intake, but also suggest that, with chronic blockade, counterregulatory mechanisms are induced to restore appetite.

Full Text

The Full Text of this article is available as a PDF (290.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beck B., Stricker-Krongrad A., Burlet A., Nicolas J. P., Burlet C. Influence of diet composition on food intake and hypothalamic neuropeptide Y (NPY) in the rat. Neuropeptides. 1990 Dec;17(4):197–203. doi: 10.1016/0143-4179(90)90036-x. [DOI] [PubMed] [Google Scholar]
  2. Billington C. J., Briggs J. E., Harker S., Grace M., Levine A. S. Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism. Am J Physiol. 1994 Jun;266(6 Pt 2):R1765–R1770. doi: 10.1152/ajpregu.1994.266.6.R1765. [DOI] [PubMed] [Google Scholar]
  3. Blomqvist A. G., Herzog H. Y-receptor subtypes--how many more? Trends Neurosci. 1997 Jul;20(7):294–298. doi: 10.1016/s0166-2236(96)01057-0. [DOI] [PubMed] [Google Scholar]
  4. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  5. Brady L. S., Smith M. A., Gold P. W., Herkenham M. Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology. 1990 Nov;52(5):441–447. doi: 10.1159/000125626. [DOI] [PubMed] [Google Scholar]
  6. Broqua P., Wettstein J. G., Rocher M. N., Gauthier-Martin B., Riviere P. J., Junien J. L., Dahl S. G. Antinociceptive effects of neuropeptide Y and related peptides in mice. Brain Res. 1996 Jun 10;724(1):25–32. doi: 10.1016/0006-8993(96)00262-4. [DOI] [PubMed] [Google Scholar]
  7. Doods H. N., Wieland H. A., Engel W., Eberlein W., Willim K. D., Entzeroth M., Wienen W., Rudolf K. BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological properties. Regul Pept. 1996 Aug 27;65(1):71–77. doi: 10.1016/0167-0115(96)00074-2. [DOI] [PubMed] [Google Scholar]
  8. Dube M. G., Xu B., Crowley W. R., Kalra P. S., Kalra S. P. Evidence that neuropeptide Y is a physiological signal for normal food intake. Brain Res. 1994 May 23;646(2):341–344. doi: 10.1016/0006-8993(94)90103-1. [DOI] [PubMed] [Google Scholar]
  9. Gerald C., Walker M. W., Criscione L., Gustafson E. L., Batzl-Hartmann C., Smith K. E., Vaysse P., Durkin M. M., Laz T. M., Linemeyer D. L. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature. 1996 Jul 11;382(6587):168–171. doi: 10.1038/382168a0. [DOI] [PubMed] [Google Scholar]
  10. Hanson E. S., Levin N., Dallman M. F. Elevated corticosterone is not required for the rapid induction of neuropeptide Y gene expression by an overnight fast. Endocrinology. 1997 Mar;138(3):1041–1047. doi: 10.1210/endo.138.3.4995. [DOI] [PubMed] [Google Scholar]
  11. Heilig M. Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding. Regul Pept. 1995 Oct 20;59(2):201–205. doi: 10.1016/0167-0115(95)00103-i. [DOI] [PubMed] [Google Scholar]
  12. Heilig M., Widerlöv E. Neurobiology and clinical aspects of neuropeptide Y. Crit Rev Neurobiol. 1995;9(2-3):115–136. [PubMed] [Google Scholar]
  13. Hulsey M. G., Pless C. M., White B. D., Martin R. J. ICV administration of anti-NPY antisense oligonucleotide: effects on feeding behavior, body weight, peptide content and peptide release. Regul Pept. 1995 Oct 20;59(2):207–214. doi: 10.1016/0167-0115(95)00110-w. [DOI] [PubMed] [Google Scholar]
  14. Jhanwar-Uniyal M., Beck B., Burlet C., Leibowitz S. F. Diurnal rhythm of neuropeptide Y-like immunoreactivity in the suprachiasmatic, arcuate and paraventricular nuclei and other hypothalamic sites. Brain Res. 1990 Dec 17;536(1-2):331–334. doi: 10.1016/0006-8993(90)90045-d. [DOI] [PubMed] [Google Scholar]
  15. Kanatani A., Ishihara A., Asahi S., Tanaka T., Ozaki S., Ihara M. Potent neuropeptide Y Y1 receptor antagonist, 1229U91: blockade of neuropeptide Y-induced and physiological food intake. Endocrinology. 1996 Aug;137(8):3177–3182. doi: 10.1210/endo.137.8.8754736. [DOI] [PubMed] [Google Scholar]
  16. Lacroix J. S., Mosimann B. L. Attenuation of allergen-evoked nasal responses by local pretreatment with exogenous neuropeptide Y in atopic patients. J Allergy Clin Immunol. 1996 Sep;98(3):611–616. doi: 10.1016/s0091-6749(96)70095-7. [DOI] [PubMed] [Google Scholar]
  17. Levine A. S., Billington C. J. Why do we eat? A neural systems approach. Annu Rev Nutr. 1997;17:597–619. doi: 10.1146/annurev.nutr.17.1.597. [DOI] [PubMed] [Google Scholar]
  18. Levine A. S., Morley J. E. Neuropeptide Y: a potent inducer of consummatory behavior in rats. Peptides. 1984 Nov-Dec;5(6):1025–1029. doi: 10.1016/0196-9781(84)90165-7. [DOI] [PubMed] [Google Scholar]
  19. Li B. H., Rowland N. E. Effect of chronic dexfenfluramine on Fos in rat brain. Brain Res. 1996 Jul 29;728(2):188–192. doi: 10.1016/0006-8993(96)00397-6. [DOI] [PubMed] [Google Scholar]
  20. Lopez-Valpuesta F. J., Nyce J. W., Griffin-Biggs T. A., Ice J. C., Myers R. D. Antisense to NPY-Y1 demonstrates that Y1 receptors in the hypothalamus underlie NPY hypothermia and feeding in rats. Proc Biol Sci. 1996 Jul 22;263(1372):881–886. doi: 10.1098/rspb.1996.0130. [DOI] [PubMed] [Google Scholar]
  21. Marks J. L., Waite K., Li M. Effects of streptozotocin-induced diabetes mellitus and insulin treatment on neuropeptide Y mRNA in the rat hypothalamus. Diabetologia. 1993 Jun;36(6):497–502. doi: 10.1007/BF02743264. [DOI] [PubMed] [Google Scholar]
  22. Morley J. E., Flood J. F. The effect of neuropeptide Y on drinking in mice. Brain Res. 1989 Aug 7;494(1):129–137. doi: 10.1016/0006-8993(89)90151-0. [DOI] [PubMed] [Google Scholar]
  23. O'Shea D., Morgan D. G., Meeran K., Edwards C. M., Turton M. D., Choi S. J., Heath M. M., Gunn I., Taylor G. M., Howard J. K. Neuropeptide Y induced feeding in the rat is mediated by a novel receptor. Endocrinology. 1997 Jan;138(1):196–202. doi: 10.1210/endo.138.1.4899. [DOI] [PubMed] [Google Scholar]
  24. O'Shea R. D., Gundlach A. L. NPY mRNA and peptide immunoreactivity in the arcuate nucleus are increased by osmotic stimuli: correlation with dehydration anorexia. Peptides. 1995;16(6):1117–1125. doi: 10.1016/0196-9781(95)00075-u. [DOI] [PubMed] [Google Scholar]
  25. Pau M. Y., Pau K. Y., Spies H. G. Characterization of central actions of neuropeptide Y on food and water intake in rabbits. Physiol Behav. 1988;44(6):797–802. doi: 10.1016/0031-9384(88)90065-0. [DOI] [PubMed] [Google Scholar]
  26. Ramirez I. Chemoreception for fat: do rats sense triglycerides directly? Appetite. 1992 Jun;18(3):193–206. doi: 10.1016/0195-6663(92)90197-e. [DOI] [PubMed] [Google Scholar]
  27. Sahu A., Kalra P. S., Kalra S. P. Food deprivation and ingestion induce reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus. Peptides. 1988 Jan-Feb;9(1):83–86. doi: 10.1016/0196-9781(88)90013-7. [DOI] [PubMed] [Google Scholar]
  28. Sahu A., Sninsky C. A., Kalra P. S., Kalra S. P. Neuropeptide-Y concentration in microdissected hypothalamic regions and in vitro release from the medial basal hypothalamus-preoptic area of streptozotocin-diabetic rats with and without insulin substitution therapy. Endocrinology. 1990 Jan;126(1):192–198. doi: 10.1210/endo-126-1-192. [DOI] [PubMed] [Google Scholar]
  29. Sahu A., Sninsky C. A., Kalra S. P. Evidence that hypothalamic neuropeptide Y gene expression and NPY levels in the paraventricular nucleus increase before the onset of hyperphagia in experimental diabetes. Brain Res. 1997 May 2;755(2):339–342. doi: 10.1016/s0006-8993(97)00192-3. [DOI] [PubMed] [Google Scholar]
  30. Schaffhauser A. O., Stricker-Krongrad A., Brunner L., Cumin F., Gerald C., Whitebread S., Criscione L., Hofbauer K. G. Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides. Diabetes. 1997 Nov;46(11):1792–1798. doi: 10.2337/diab.46.11.1792. [DOI] [PubMed] [Google Scholar]
  31. Schaffhauser A. O., Whitebread S., Haener R., Hofbauer K. G., Stricker-Krongrad A. Neuropeptide Y Y1 receptor antisense oligodeoxynucleotides enhance food intake in energy-deprived rats. Regul Pept. 1998 Sep 25;75-76:417–423. doi: 10.1016/s0167-0115(98)00097-4. [DOI] [PubMed] [Google Scholar]
  32. Schwartz M. W., Sipols A. J., Grubin C. E., Baskin D. G. Differential effect of fasting on hypothalamic expression of genes encoding neuropeptide Y, galanin, and glutamic acid decarboxylase. Brain Res Bull. 1993;31(3-4):361–367. doi: 10.1016/0361-9230(93)90228-4. [DOI] [PubMed] [Google Scholar]
  33. Shibasaki T., Oda T., Imaki T., Ling N., Demura H. Injection of anti-neuropeptide Y gamma-globulin into the hypothalamic paraventricular nucleus decreases food intake in rats. Brain Res. 1993 Jan 22;601(1-2):313–316. doi: 10.1016/0006-8993(93)91727-a. [DOI] [PubMed] [Google Scholar]
  34. Stanley B. G., Leibowitz S. F. Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci. 1984 Dec 24;35(26):2635–2642. doi: 10.1016/0024-3205(84)90032-8. [DOI] [PubMed] [Google Scholar]
  35. Stricker-Krongrad A., Beck B., Burlet C. Enhanced feeding response to neuropeptide Y in hypothalamic neuropeptide Y-depleted rats. Eur J Pharmacol. 1996 Jan 4;295(1):27–34. doi: 10.1016/0014-2999(95)00647-8. [DOI] [PubMed] [Google Scholar]
  36. Williams G., Gill J. S., Lee Y. C., Cardoso H. M., Okpere B. E., Bloom S. R. Increased neuropeptide Y concentrations in specific hypothalamic regions of streptozocin-induced diabetic rats. Diabetes. 1989 Mar;38(3):321–327. doi: 10.2337/diab.38.3.321. [DOI] [PubMed] [Google Scholar]
  37. Wyss P., Stricker-Krongrad A., Brunner L., Miller J., Crossthwaite A., Whitebread S., Criscione L. The pharmacology of neuropeptide Y (NPY) receptor-mediated feeding in rats characterizes better Y5 than Y1, but not Y2 or Y4 subtypes. Regul Pept. 1998 Sep 25;75-76:363–371. doi: 10.1016/s0167-0115(98)00089-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES